Quote:

---

No wonder that up to 95% of cancer drugs brought to the bedside in clinical trials fail to win FDA approval. And among the other 5%, many hardly deserve their approvals, as their improvements to survival only last a few months and for a fraction of the treated cases.

---

from

Insert-tag-herehttps://www.wsj.com/articles/cancer-is-still-beating-uswe-need-a-new-start-11570206319?mod=hp_lead_pos9

It is an interesting article advocating an approach targeting early detection of cancers adapted from Dr. Raza’s new book, “The First Cell and the Human Costs of Pursuing Cancer to the Last”